中京電子(002579.SZ):珠海億盛45%股權及元盛電子23.88%股權完成過户及工商變更
格隆匯11月20日丨中京電子(002579.SZ)公佈,公司於2019年11月7日收到中國證監會核發的《關於核准惠州中京電子科技股份有限公司向胡可等發行股份、可轉換公司債券購買資產並募集配套資金的批覆》。
公司收到中國證監會的核準文件後積極開展標的資產交割工作。截至目前,本次交易標的資產珠海億盛科技開發有限公司(以下簡稱“珠海億盛”)45.00%股權和珠海元盛電子科技股份有限公司(以下簡稱“元盛電子”)23.88%股權已完成過户手續及相關工商變更登記,公司直接及間接控制的珠海億盛和元盛電子的股權比例均達到100%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.